Subscribe to Updates

    Get the latest creative news from CRYPTO NOUNCE.

    What's Hot

    BlackRock Multi-Sector Income Trust (NYSE:BIT) Stock Passes Below 50-Day Moving Average of $14.85

    March 30, 2023

    Fetch.ai Raises $40M Led by DWF Labs at Valuation of $250M

    March 30, 2023

    ING and Salt Edge join forces for widening open banking use cases

    March 30, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram Vimeo
    Cryptonounce.com
    Contact
    • Business
      • Deals
      • investors
      • IPO
      • Startups
      • Wall Street
    • Markets
      • Bonds
      • Commodities & Futures
      • Currencies
      • Funds & ETFs
      • Stocks
    • Crypto
      • Alticoins News
      • Binance News
      • Bitcoins News
      • Blockchain News
      • Ethereum News
      • Token Sales News
      • XRP News
    • Technology
      • Artificial Intelligence
      • Big Data
      • Cloud Computing
      • Cybersecurity
      • Gaming
      • Internet of Things
      • Mobile
      • Social Media
      • Transportation
      • VR & AR
    • FinTech
    • Personal finance
    • Grides
      • Crypto
      • FinTech
      • Investing
      • Personal Finance Guides
      • Techonology
    • Tools
      • Coins
      • ICO List
      • Organigations
      • Events
    Cryptonounce.com
    Home » Atai says its depression treatment failed in a mid-stage clinical trial
    Markets

    Atai says its depression treatment failed in a mid-stage clinical trial

    AdmincryptBy AdmincryptJanuary 6, 2023No Comments1 Min Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Shares of Atai Life Sciences NV
    ATAI,
    -30.80%

    tumbled about 44% in premarket trading on Friday after the company said a Phase 2a clinical trial evaluating a ketamine therapy for treatment-resistant depression did not meet the primary endpoint. Atai’s stock has declined 60.1% over the past year, while the S&P 500
    SPX,
    +2.28%

    is down 19.0%.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleFate Therapeutics stocks heads for record selloff after Janssen collaboration terminated and job cuts
    Next Article Silvergate Capital stock falls another 8.5%; JPMorgan downgrades company to neutral
    Admincrypt
    • Website

    Related Posts

    BlackRock Multi-Sector Income Trust (NYSE:BIT) Stock Passes Below 50-Day Moving Average of $14.85

    March 30, 2023

    BlackRock calls on clients to rethink hedging strategy after UK pension crisis By Reuters

    March 30, 2023

    FirstEnergy (NYSE:FE) PT Lowered to $40.00

    March 30, 2023

    Cyclone Gabrielle industry loss estimated NZ $1.543bn by PERILS

    March 30, 2023

    Leave A Reply Cancel Reply

    Our Picks
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    Funds & ETFs

    BlackRock Multi-Sector Income Trust (NYSE:BIT) Stock Passes Below 50-Day Moving Average of $14.85

    By AdmincryptMarch 30, 20230

    BlackRock Multi-Sector Income Trust (NYSE:BIT – Get Rating)’s share price passed below its fifty day…

    Fetch.ai Raises $40M Led by DWF Labs at Valuation of $250M

    March 30, 2023

    ING and Salt Edge join forces for widening open banking use cases

    March 30, 2023

    Parloa raises $21M to add a little automation to contact centers

    March 30, 2023

    Subscribe to Updates

    Get the latest creative news from CRYPTO NOUNCE.

    NEWS
    • Business
    • Crypto
    • Blockchain
    • Markets
    • Technology
    FEATURED SECTIONS
    • Coins
    • ICO List
    • Organigations
    • Events
    • Grides
    FEATURED LINKS
    • Story of the day
    • Videos
    • Infographics
    CONNECT WITH US
    • Facebook
    • Twitter
    • Telegram
    • LinkedIn
    • Pinterest
    ABOUT US
    • Contact
    • Advertise
    • Sitemap
    Copyright © 2023 Cryptonounce All rights reserved. Cryptonounce.
    • Home
    • Buy Now

    Type above and press Enter to search. Press Esc to cancel.

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?